Meds on Demand by Maisha Meds is a digital tool that gives patients access to high-impact health products by helping healthcare providers to source quality medication, manage sales and inventory, and view prices, stock levels and delivery times. Aditionally, Meds on Demand functions as a digital medication reimbursement platform through which global health funders can subsidize products.
The venture builds upon the business model that pharmacies pay a small commission fee on placed orders and that collected data can be sold to regulators and pharma firms additionally.
Up until now, 1.5 million patients and more than 350 pharmacies could be reached by Meds on Demand. The venture was able to secure more than 4,5 million € in funding, whereof the Bill & Melinda Gates Foundation and USAID each invested 1.5 million in 2019. In 2020, Maisha Meds expanded to Tanzania and Uganga, started a two-year pilot to improve antenatal care for pregnant women and an Evaluation with UC Berkeley concerning Malaria.
Developed in lot 3 // Challenge: How might we improve access to medicines and medical diagnoses in Kenya?
Further information: https://maishameds.org/